# OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study

> **NCT00134160** · PHASE4 · COMPLETED · sponsor: **OSCAR Study** · enrollment: 1000 (estimated)

## Conditions studied

- Hypertension
- Cardiovascular Diseases

## Interventions

- **DRUG:** Olmesartan medoxomil
- **DRUG:** Calcium channel blockers (amlodipine, azelnidipine)

## Key facts

- **NCT ID:** NCT00134160
- **Lead sponsor:** OSCAR Study
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2010-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00134160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00134160, "OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00134160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*